熱門資訊> 正文
贝顿、迪金森被指控阻碍疝气网片市场竞争
2025-12-23 06:54
- Tela Bio (TELA) has filed a lawsuit accusing Becton, Dickinson (BDX) of stymying competition in the US market for surgical hernia mesh.
- The lawsuit, filed on Dec. 19 in a Philadelphia federal court, claims that Becton, Dickinson used its dominance in permanent hernia mesh and resorbable hernia mesh to crowd out Tela Bio's competing OviTex product.
- Tela Bio is accusing Becton, Dickinson of retribution against hospitals and other healthcare providers for purchasing OviTex as well as using long-term contracts to entice customers to purchases hernia mesh only from Becton Dickinson, Reuters reported.
- In October 2024, Becton, Dickinson said it settled the "vast majority" of claims alleging safety concerns with its hernia mesh products.
More on Becton, Dickinson, TELA Bio
- Becton, Dickinson: Our New, Long, Special Situation Investment
- TELA Bio, Inc. (TELA) Q3 2025 Earnings Call Transcript
- Becton, Dickinson and Company 2025 Q4 - Results - Earnings Call Presentation
- Waters raised to Outperform at Wolfe on BD Life Sciences deal
- 1578 Partners initiates new position in Becton, Dickinson and Company in Q3
推薦文章
谷歌年初在人工智能競賽中落后，卻在2025年末登頂行業榜首
華盛早報 | 美聯儲主席熱門人選哈塞特：降息節奏仍需加速！英偉達稱春節前向中國交付H200芯片；中芯國際對部分產能漲價10%
12月24日外盤頭條：美國消費者信心連續第五個月下滑 金銀連續兩日刷新歷史新高 特朗普提美聯儲主席必要條件
美聯儲主席候選人哈塞特：美國在降息方面已嚴重滯后
美股機會日報 | 黃金再創新高！現貨黃金逼近4500美元關口；甲骨文CEO埃里森為派拉蒙提供鉅額資金擔保
資金覆盤 | 北水淨買入港股6.11億港元，加倉阿里超13億港元，賣出騰訊超10億港元
首日最高狂飆337%，港股IPO「AI含量」拉滿！壁仞、智譜、MiniMAX密集衝刺，AI上市潮已至？
年終盤點 | 流動性翻倍！1.4萬億北水買爆港股，2025年哪些公司獲重點掃貨？
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
